Condrotide HA
Main Components:
10mg/ml Polynucleotides HPT®, 10mg/ml Linear Hyaluronic Acid and Mannitol
Pack:
2,5ml pre-filled glass syringe (no needle supplied within the pack)
Condrotide HA is indicated for patients suffering from osteoarthritis
Condrotide HA is a temporary substitute for the synovial fluid, which, thanks to its viscoelastic and lubricating properties, promotes the restoration of the joints’ rheological conditions. By improving the characteristics of the synovial fluid, the product acts by protecting the joint and promoting the physiological repair mechanism of the articular cartilage
Knee, shoulder, hip, and ankle
Indicated for painful conditions that affect the joints and that can be attributed to degenerative, post-injury ailments or to alterations of the joints.
Aqua, polynucleotides (1%), sodium hyaluronate (1%), mannitol, sodium phosphate, disodium phosphate
Polynucleotides HPT® 10mg/ml, Hyaluronic Acid 10mg/ml
2.5ml pre-filled glass syringe (no needle supplied within the pack)
Condrotide HA should be injected inside the articular cavity with the use of a sterile needle with a diameter between 18G and 22G, generally 20G
The recommended treatment regimen involves 3 injections in the joint to be treated, one to three weeks apart
